Skip to content
Search

Latest Stories

Ceuta Group appoints P&G’s Michael Yates as chief operating officer

Ceuta Group has appointed Michael Yates as chief operating officer (COO).

In his new role, he will focus on the exploration of future acquisitions to support the Group’s growth plans and ensure it continues to provide innovative services and unlock new opportunities for its clients.


Prior to joining Ceuta Group, Yates was associated with Procter & Gamble (P&G) for more than 25 years. His career started in the UK and progressed through senior commercial and managing director roles across Europe, Africa and Asia.

During his time at P&G, Yates gained insight and experience in building brands in the UK and globally. He has broad category experience across food & drink as well as health, wellness and personal care, having worked with brands such as Pringles, Sunny Delight, Oral B, Vicks, Head & Shoulders and Pantene.

With extensive international experience, Michael brings client-side knowledge and insight of successfully expanding brands and adapting business models for markets across the globe. His appointment bolsters Ceuta Group’s leadership structure and will support the Group’s growth plans and delivery of superior client service.

Commenting on his appointment, Yates said, “Having known and respected Ceuta Group for many years for its strong culture and unique business model, I am excited to be joining Ceuta Group as COO. I’m looking forward to meeting both longstanding and new clients to hear how we can support them in their growth ambitions both in the UK and internationally.”

Yates’s immediate focus will be to meet with and hear from clients, colleagues and partners to help inform the Group’s future thinking and strategic choices.

Yates added, “It’s a challenging time for brands and businesses, and so effective collaboration between the Group and our clients has never been more important. Now is not the time for brands to stand still, business models need to be constructively disrupted to ensure they are responsive to changing consumer needs and continue to deliver value. I look forward to working with our clients across the health and personal care industry and building their brands across multiple channels and markets.”

Edwin Bessant, Ceuta Group CEO, said, “We’re delighted to welcome Michael to Ceuta Group. His international experience and focus on collaboration will be an asset for the Group and our clients.

“The introduction of the COO role to our leadership team comes at a pivotal time and will support the Group’s plans for growth. This evolution will also allow us to align even closer to our clients to help them successfully adapt and navigate today’s changing environment.”

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less